Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2012 · 10-Q
Revenue$5.27B$5.27B−46.4% vs Q3 2011 Net Income$1.94B$1.94B+540.8% vs Q3 2011 EPS Diluted$1.21$1.21+536.8% vs Q3 2011 Gross Profit$2,581,000,000−55.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,519,502,000+15.2% Free Cash Flowderived$2,988,755,000+14.8% Margins · derivedGross margin49.0%−10.5 pt vs Q3 2011
Operating margin5.9%−0.2 pt vs Q3 2011
Net margin36.9%+33.8 pt vs Q3 2011
ended Sep 30, 2012 · filed Nov 7, 2012 · 38 d after period end